BioNTech CEO Uğur Şahin disposes of USD 6,090,748 in common shares

BNTX•2026-09-28

BioNTech CEO Uğur Şahin sold 61,000 ordinary shares from Sept. 25-28 at prices of USD 98.4682 to USD 98.6882 per share, leaving him with 280,209 directly held shares.

1. Share sales

Filings show that Şahin sold 61,000 BioNTech ordinary shares from Sept. 25-28, at prices ranging from USD 98.4682 to USD 98.6882 per share. His directly held stake fell to 280,209 shares after the transactions, which were executed under a Rule 10b5-1 trading plan adopted June 3, 2026.

Sources

BioNTech CEO Uğur Şahin disposes of USD 6,090,748 in common shares

Sec

BioNTech CEO Uğur Şahin disposes of USD 6,090,748 in common shares

1. Share sales

Related News

AtlasClear amends Form 4 filings to correct insider share purchases as open-market buys

Jefferies Q3 revenue beats estimates on growth in advisory, underwriting fees

AAR to buy majority stake in aircraft maintenance firm MRO Holdings for $1.8 billion

Sources

BioNTech CEO Uğur Şahin disposes of USD 6,090,748 in common shares

U.S. Physical Therapy enters $170.6 million forward-starting interest rate swap with Bank of America

BillionToOne SVP John Roderick ten Bosch sells 1,416 shares worth $169,920